Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:04 pm Purchase |
2024-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
Austin Che | 2,372,573 5.000% |
2,372,573 (New Position) |
Filing History |
| 2025-02-14 4:03 pm Purchase |
2025-02-14 | 13D | Ginkgo Bioworks Holdings, Inc. DNA |
Reshma P. Shetty | 4,716,084 9.500% |
4,716,084 (New Position) |
Filing History |
| 2025-01-30 9:58 pm Sale |
2024-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
The Vanguard Group | 2,013,548 4.450% |
-592,205 (-22.73%) |
Filing History |
| 2025-01-10 9:25 pm Unchanged |
2024-09-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
ARK Investment Management LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-11-14 4:31 pm Purchase |
2024-09-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
VIKING GLOBAL INVESTORS LP | 3,577,128 8.300% |
3,577,128 (New Position) |
Filing History |
| 2024-11-12 3:58 pm Unchanged |
2024-09-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
The Vanguard Group | 2,605,753 6.040% |
0 (Unchanged) |
Filing History |
| 2024-11-04 11:56 am Purchase |
2024-09-30 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
The Vanguard Group | 2,605,753 6.040% |
2,605,753 (New Position) |
Filing History |
| 2024-07-05 10:29 am Sale |
2024-06-28 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
BAILLIE GIFFORD & CO | 3,360,647 7.870% |
-2,546,658 (-43.11%) |
Filing History |
| 2024-02-14 5:08 pm Sale |
2023-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
Knight Thomas F. Jr. | 1,708,211 4.100% |
-165,192 (-8.82%) |
Filing History |
| 2024-02-14 5:06 pm Sale |
2023-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
Austin Che | 2,397,462 5.600% |
-98,970 (-3.96%) |
Filing History |
| 2024-02-14 5:05 pm Sale |
2024-02-14 | 13D | Ginkgo Bioworks Holdings, Inc. DNA |
Reshma P. Shetty | 4,716,098 10.500% |
-178,615 (-3.65%) |
Filing History |
| 2024-02-14 5:03 pm Sale |
2024-02-14 | 13D | Ginkgo Bioworks Holdings, Inc. DNA |
Kelly Jason R | 2,143,808 5.000% |
-281,628 (-11.61%) |
Filing History |
| 2024-02-14 10:16 am Unchanged |
2023-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
VIKING GLOBAL INVESTORS LP | 3,577,128 8.800% |
0 (Unchanged) |
Filing History |
| 2024-02-13 5:06 pm Purchase |
2023-12-29 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
The Vanguard Group | 3,319,492 8.200% |
781,460 (+30.79%) |
Filing History |
| 2024-01-29 4:00 pm Purchase |
2023-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
ARK Investment Management LLC | 4,965,165 12.260% |
1,355,564 (+37.55%) |
Filing History |
| 2024-01-29 09:55 am Sale |
2023-12-29 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
BAILLIE GIFFORD & CO | 5,907,305 14.590% |
-197,112 (-3.23%) |
Filing History |
| 2023-02-14 5:02 pm Purchase |
2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
Austin Che | 2,496,432 6.300% |
423,410 (+20.42%) |
Filing History |
| 2023-02-14 5:01 pm Sale |
2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
Knight Thomas F. Jr. | 1,873,403 5.000% |
-3,673 (-0.20%) |
Filing History |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
VIKING GLOBAL INVESTORS LP | 3,577,128 9.360% |
700,025 (+24.33%) |
Filing History |
| 2023-02-14 12:00 pm Purchase |
2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
Anchorage Capital Group L.L.C. | 1,747,615 4.830% |
17,406 (+1.01%) |
Filing History |